TriLink BioTechnologies
Microsoft Excel-based Algorithm Predicts Cancer Prognosis
The algorithm will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training.
RecipharmCobra Biologics Announces Patent for Novel Antibiotic-Free Plasmid Maintenance System
oriSELECT plasmid maintenance system wins US and European patents.
Alnylam and Collaborators Publish new Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene
New Research shows silencing of alpha-synuclein in the Substantia Nigra of non-human primates with an RNAi therapeutic.
First Genetic Link to Common Migraine Exposed
Genetic variant may increase susceptibility to migraine triggers.
Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions
Lonza expands its custom service platform to viral vaccines and gene therapy vectors.
First Picture of Genetic Processes Inside Cell Developed at Penn State
Penn scientists used X-ray crystallography to built the first-ever image of a protein interacting with the nucleosome.
The EMBO Meeting 2010 - Advancing the life sciences
04 September 2010 - 07 September 2010

Barcelona, Spain
Submit late abstracts by 30 July & register until 15 August

Programme includes: presentations by 120 world-class researchers, e.g. Elizabeth Blackburn and Cliff Tabin, 21 workshops spanning the life sciences, stand-alone poster sessions, on-site childcare and plenty of opportunities to meet fellow scientists.
Epigenetics Europe
14 September 2010 - 15 September 2010

The second Epigenetics Europe will focus on the most recent discoveries in this field. Speakers will discuss Methylation and DNA silencing, Chromatin remodelling and ncRNA functions as well as highlighting some of the discoveries of epigenetics in disease processes.
Genomics Automation Europe
14 September 2010 - 15 September 2010

This inaugural conference will explore some of the latest technologies surrounding the genomics field. Next Generation Sequencing will be discussed as well as Alternative Sequencing Methods, Sample Preparation, Liquid Handling, Data Analysis and Storage.
Drug Analysis 2010 - Antwerp, Belgium
21 September 2010 - 24 September 2010

This international symposium is organized by the Belgian Society of Pharmaceutical Sciences (BSPS) since 1983 and will cover all aspects of pharmaceutical and biomedical analysis, including emerging domains, such as ‘omics’, process analytical technology and green analysis.
Non-coding RNAs in development
01 October 2010 - 01 October 2010

Welwyn Garden City, United Kingdom.
This meeting will focus on the discovery and characterization of non-protein coding RNAs in the context of embryogenesis and organismal development, highlighting recent technological advances for high-throughput functional genomics
This meeting has CPD accreditation.
Protein NMR/Biophysics Research Associate (BS/MS)
Novartis Institutes for BioMedical Research
We are committed to discovering innovative medicines to cure disease and improve human health. By hiring the best academic, biotech, and pharmaceutical trained scientists, we have fostered an atmosphere for drug discovery where innovation is rewarded.
Senior Account Manager/Account Director
Alto Marketing
The best career move for a well-connected marketing professional with real leadership ability and drive!
Senior Scientific Marketing Writer - Life Sciences
Alto Marketing
For a challenging career using your advanced life science background and writing strengths, please read on.
Post-doctoral position at INRA (France)
INRA
An 18-month post-doctoral position is available at INRA Clermont-Ferrand-Theix (France).The position is opened to both French and foreign applicants.
mRNA Fate and Dynamics Following microRNA-Direcged Translational Repression
Harvard Medical School

A synthetic miRNA-regulated cell line was created to track the fate of miRNA-regulated mRNA containing an exogenous luciferase mRNA as a reporter gene. In order to determine the dynamics of proteins complexing with miRNA-regulated mRNA, single molecule in situ hybridization of the target mRNA was conducted in combination with immunofluorescence to identify factors involved in degradation, storage, and reactivation of miRNA-regulated mRNA.
Digital Volumetric Imaging of Angiogenesis in Tissue Engineered Constructs
University of Washington

Accurate identification of functional vasculature is of critical importance in evaluating construct integration. Digital volumetric imaging (DVI) is an automated serial sectioning and microscopic imaging technique that can bridge the resolution gap between micro-computed tomography and conventional histology. We use DVI to study in vivo vascularization of tissue engineering constructs in a variety of settings.
  
Biomarker Qualification: Europe is ready, are you?

Patricia Hurley, Division Head, ERA Consulting, speaking at European Biomarkers Summit 2009
Genomic to the Epigenomic Era: Steps Towards Biomarker Discovery

Mohammad Hoque, Assistant Professor, Johns Hopkins University, speaking at European Biomarkers Summit 2009
DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles
Business Insights

The advent of DNA sequencing technology has had a vast impact on the field of drug development. It has played a key role in the success of the Human Genome Project, which has made it an essential tool for genetic analysis. Advanced technological developments in microarrays, bioinformatics and similar tools have increased the scope of applications and services.
Single Cell Analysis 2010: the New Frontier for 'Omics Market Report
Select Biosciences Ltd

Successful conversion of opportunity to profit requires a detailed understanding of this emerging market. Single-Cell Analysis 2010: the New Frontier for ’Omics explains the key technologies, applications, unmet needs and trends. The 128-page report includes a survey of more than 300 participants, interviews with 5 leading experts, analyses of 25 companies and 16 academic programs and a 5-by-7 quantitative market model of technologies and applications.
Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Business Insights

There has been a significant transition in the diagnostic techniques created with increasing technological innovations. In the future, the focus will be on genetic study and disease predisposition, which will test patients' probability of acquiring a disease or a disorder, enabling precautionary steps.